Transcript 170203 Programma Case I presentaties.xlsx

Februari 3rd 2017 MII first year master students will conclude the case with a presentation of the results.
Program Track Medical Imaging and Intervention (NH115)
Rene Brouwer en Anique Grob
9.00‐9.30
Group 1
Joosje de Bakker
AdditionalguidelinesforveinmappingwiththeuseofRI,comorbiditiesandpulsalitytoaccesthevesselwaal
Evelien van Genugten
andpotentionalstenosistoachievebetterAVFmaturation
Lisanne Roelofs
Angelique van Vlaenderen
9.30‐10.00
10.00‐10.30
10.45‐11.15
11.15‐11.45
11.45‐12.15
Group 2
Rick Bergmans
Reneé Geraats
Stephan Romeijn
Madelon Voets
Group 3
Timon ter Braak
Jane Gruisen
Philippe de Rooy
Group 4
Mechteld Brasz
Jurre Klaassen
Huib Ruitenbeek
Group 5
Tessa Brouwer
Nienke de Laat
Bas Schippers
Nienke Wassenaar
Group 6
Nadine Coorens
Alexander Lau
MarkSelles
Beau van Woudenberg
Evaluatingvenouselasticityasadiagnosticparameterdetermineoptimalvascularaccesssurgeryin
haemodialysis
Theinfluenceofinter‐observervariabilityonvascularmapping
Effectofincreasingthehandtemperatureusingheatelementsonthediameterofthecephalicveinandthe
diameterandflowintheradialarteryforassessmentofvascularaccessviaarteriovenousfistulafor
hemodialysis.
Intraandinterobserverreliabilityofultrasoundimagingforpreoperativevenousmapping
Pauze
Lioe-Fee de Geus-Oei en Bennie ten Haken
13.00‐13.30
13.30‐14.00
14.00‐14.30
Group 7
Rob van Dijk
Chien Nguyen
Michelle Simons
Lisanne Zwart
Group 8
Mathijs Disselhof
Jos Nijhof
Stefan Smorenburg
Jasper van der Graaf
Group 9
Lotte van Dongen
Liset Noltes
Ilse Spenkelink
Annelies Winkelhorst
14.45‐15.15
Group 10
Maaike Dotinga
Tom Perik
Merel van der Stelt
Ellis Winters
15.15‐15.45
Group 11
José Enthoven
Maarten Poirot
Bart Thomson
15.45‐16.15
Group 12
Matthijs Fitski
Jonas Riksen
Koen Verdonschot
Possibilitiesofimagingmodalitiesinmonitoringearlytreatmentresponseofneoadjuvantchemotherapyin
breastcancer.
Diffusereflectancespectroscopyinreducingbreastcancerre‐excisionrates
ContrastEnhancedUltrasoundwithBR55coatedmicrobubblescomparedtoMRIinthediagnosisofbreast
cancer
F18‐FESPETpatientspecificdosingoffulvestrantonestrogenreceptorsinpost‐menopausalpatientswith
estrogenreceptorpositivebreastcancer.